Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$26,000.00
Apr 1, 2025
For-profit organization
CLEIO inc.-2025-2026-1030113
1030113
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
$33,000.00
Apr 1, 2025
For-profit organization
PREMIER BLOC INC./First Block INC.-2025-2026-1030114
1030114
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
$12,000.00
Apr 1, 2025
For-profit organization
Studio d'Armes Inc.-2025-2026-1030115
1030115
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
$499,520.00
Apr 1, 2025
For-profit organization
UK Biomanufacturing - 10136110 - NextGen ADC Platform-Engineering High-Yielding Expression Vectors and Peptide Linker Tags for Advanced ADC Production
1030116
“As part of the international consortium project “NextGen ADC Platform: Engineering High-Yielding Expression Vectors and Peptide Linker Tags for Advanced ADC Production”, this project will aim to develop a novel expression platform for high-level production of monoclonal antibodies (mAbs) with optimized affinity peptide tags for development of advanced antibody drug conjugates (ADCs). This innovative approach eliminates the need for extra conjugation and purification steps, reducing the complexity and cost of ADC production and ultimately produces ADCs that can be reconstituted in the clinic, thereby simplifying the production processes.
The project brings together the expertise from Daresbury Proteins Ltd ("Daresbury"), a United Kingdom-based company specializing in novel expression platforms, the NRC and Eurofins CDMO Alphora Inc. ("Alphora").
$23,000.00
Apr 1, 2025
For-profit organization
SOLUTIONS INFOBEC INC.-2025-2026-1030118
1030118
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
$124,000.00
Apr 1, 2025
Not-for-profit organization or charity
Provision of Research Services and Expertise to Canadian Small and Medium-sized Enterprises (SMEs)
1030122
Provision of Research Services and Expertise to Canadian Small and Medium-sized Enterprises (SMEs)
$30,000.00
Apr 1, 2025
For-profit organization
Pilot Trainee
1030143
Superwake is developing a pilot training program to grow its remote sensing as a service business. The goal is to teach new pilots all the skills required to operate fixed-wing, long-range, electric drones with a 25 kg mass and a 5.3 m wingspan. Skills include mission planning, regulatory compliance, safely handling lithium-ion batteries, and manual flying with remote controls.
$100,000.00
Apr 1, 2025
For-profit organization
Design and development of multiple enhancements to the firm's software suite
1030144
The proposed project will enhance the firm's existing platform to integrate AI-driven features and new functionality to automate key tasks and improve existing tools for reputation management, practice communication, patient engagement, and patient lead generation.
$500,000.00
Apr 1, 2025
For-profit organization
E!6936 PFASGUARD: PFAS Detection and Treatment System
1030145
This project aims to develop a new PFAS (per/polyfluoroalkyl substances) destruction technology that integrates rapid PFAS detection (particle-induced gamma emission) to be developed by firm’s partner (Forever Analytical Solutions B.V., Netherlands), and real-time, data/AI-driven treatment control into firm’s treatment technology. The expected outcome is a reduction of material and energy costs of treatment compared to current standards, enabling economically feasible PFAS destruction, as well as providing real-time treatment performance verification.
$360,000.00
Apr 1, 2025
For-profit organization
AI Pharmacy Operator
1030148
This project aims to enhance prescription processing, billing accuracy, and communication efficiency using AI-driven automation. By optimizing workflows, reducing errors, and automating manual tasks, the initiative seeks to decrease prescription processing times, minimize claim rejections, and improve communication between pharmacies, physicians, and patients. The anticipated outcomes include increased efficiency, reduced administrative burden, and improved healthcare service delivery while maintaining compliance with regulatory and privacy standards.